PDL BioPharma Probability of Future Stock Price Finishing Over 2.78

PDL BioPharma's future price is the expected price of PDL BioPharma instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of PDL BioPharma performance during a given time horizon utilizing its historical volatility. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
  
Please specify PDL BioPharma's target price for which you would like PDL BioPharma odds to be computed.

PDL BioPharma Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of PDL BioPharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for PDL BioPharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
PDL BioPharma is not yet fully synchronised with the market data
PDL BioPharma has some characteristics of a very speculative penny stock
PDL BioPharma has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 27.76 M. Net Loss for the year was (39.18 M) with profit before overhead, payroll, taxes, and interest of 13.43 M.
PDL BioPharma currently holds about 105.45 M in cash with (56.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.93.
Over 97.0% of the company shares are owned by institutional investors

PDL BioPharma Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of PDL Stock often depends not only on the future outlook of the current and potential PDL BioPharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. PDL BioPharma's indicators that are reflective of the short sentiment are summarized in the table below.
Average Daily Volume In Three Month2.84M

PDL BioPharma Technical Analysis

PDL BioPharma's future price can be derived by breaking down and analyzing its technical indicators over time. PDL Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of PDL BioPharma. In general, you should focus on analyzing PDL Stock price patterns and their correlations with different microeconomic environments and drivers.

PDL BioPharma Predictive Forecast Models

PDL BioPharma's time-series forecasting models is one of many PDL BioPharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary PDL BioPharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about PDL BioPharma

Checking the ongoing alerts about PDL BioPharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for PDL BioPharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
PDL BioPharma is not yet fully synchronised with the market data
PDL BioPharma has some characteristics of a very speculative penny stock
PDL BioPharma has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 27.76 M. Net Loss for the year was (39.18 M) with profit before overhead, payroll, taxes, and interest of 13.43 M.
PDL BioPharma currently holds about 105.45 M in cash with (56.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.93.
Over 97.0% of the company shares are owned by institutional investors
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Consideration for investing in PDL Stock

If you are still planning to invest in PDL BioPharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PDL BioPharma's history and understand the potential risks before investing.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities